Oral montelukast treatment of preschool-aged children with acute asthma

A single 4-mg tablet of montelukast had the potential to provide additive clinical benefit in mild to moderate acute asthma in preschool-aged children when administered concomitantly with short-acting β2-agonist bronchodilators as the initial treatment.